Fundraising FoxTransformative Biotech
1 known investors
Find your way into Transformative Biotech
Transformative Biotech develops patented extraction-free direct-to-PCR chemistry that enables PCR testing directly from raw swab and saliva samples without nucleic acid purification, aiming to lower cost and speed up turnaround. The technology targets molecular diagnostics for infectious diseases and cancer, and is intended for research, clinical testing, and point-of-care use.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Transformative Biotech do?
- Transformative Biotech develops patented extraction-free direct-to-PCR chemistry that enables PCR testing directly from raw swab and saliva samples without nucleic acid purification, aiming to lower cost and speed up turnaround. The technology targets molecular diagnostics for infectious diseases and cancer, and is intended for research, clinical testing, and point-of-care use.
- Who founded Transformative Biotech?
- Transformative Biotech was founded by Russ Hullet.
- Who are Transformative Biotech's investors?
- Transformative Biotech's investors include Colorado BioScience Association.